[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100437614":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":39,"locations":48,"responsibleParty":65,"collaborators":69,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":31,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":31,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":31,"overallStatus":51,"whyStopped":31,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Children's Hospital of Orange County","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Neurostim Device","EXPERIMENTAL","Patients in this group will receive the active devices for the initial 4 study weeks.",[13],"Device: percutaneous electrical nerve-field stimulation, PENFS",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham Neurostim Device","SHAM_COMPARATOR","Patients in this group will receive the sham devices for the initial 4 study weeks. However, they will be offered the 4 active devices after.",[19],"Device: percutaneous electrical nerve-field stimulation, PENFS (sham device)",{"label":21,"type":10,"description":22,"interventionNames":23},"COVID Active Neurostim Device","Patients in this group will receive the active devices for the 6 study weeks.",[24],"Device: percutaneous electrical nerve-field stimulation, PENFS (COVID active device)",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DEVICE","percutaneous electrical nerve-field stimulation, PENFS","A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear",[9],null,{"type":27,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"percutaneous electrical nerve-field stimulation, PENFS (sham device)","A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear. The sham device will not deliver field stimulation to the ear.",[15],{"type":27,"name":37,"description":29,"armGroupLabels":38,"otherNames":31},"percutaneous electrical nerve-field stimulation, PENFS (COVID active device)",[21],[40,45],{"name":41,"role":42,"phone":43,"phoneExt":31,"email":44},"Pari Mokhtari","CONTACT","714-509-8765","pari.mokhtari@choc.org",{"name":46,"role":42,"phone":43,"phoneExt":31,"email":47},"Jamie Janchoi","jamie.janchoi@choc.org",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"CHOC Children's","RECRUITING","Orange","California","92868","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-117.85311,33.78779,{"lat":61,"lon":60},[64],{"name":41,"role":42,"phone":31,"phoneExt":31,"email":44},{"type":66,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Ashish Chogle","Principal Investigator",[70],{"name":71,"class":72},"Innovative Health Solutions","INDUSTRY","100437614","percutaneous-electrical-nerve-field-stimulation-penfs-in-patients-with-post-concussion-syndrome-pcs-100437614",false,"NCT04978571","Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)","Concussion:\n\nInclusion Criteria:\n\n* Clinical diagnosis of Post-Concussion Syndrome\n* Post-Concussion Symptoms for at least 3 months along with lack of other explanation for their symptoms\n* English and Spanish-speaking families\n\nExclusion Criteria:\n\n* Seizure disorders\n* Significant developmental delay\n* Infection or severe dermatological condition of ear\n* Bleeding disorders\n* Implanted electrical device\n\nCOVID:\n\nInclusion Criteria\n\n* Child is in between the ages 11-18\n* Child is present at CHOC Neurology clinic post covid-19 symptoms of more than 3 months duration along with lack of other explanation for their symptoms\n* English-speaking and Spanish-speaking families\n\nYou cannot participate in this study if you meet the following exclusion criteria:\n\n* Children with significant developmental delay, infection or severe dermatological condition of ear, bleeding disorders, or having any implanted electrical device will be excluded.\n* Are not able to attend Friday appointments for the Neurostim placements.","ALL","11 Years","18 Years",{"count":84,"type":85},125,"ESTIMATED","INTERVENTIONAL",[88],"NA","The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms.\n\nAn additional purpose of this study is to demonstrate that PENFS improves functioning in children with post Covid-19 symptoms.",[91,92,93],"Post-Concussion Syndrome","COVID Long-Haul","COVID-19","2026-03-16",{"date":96,"type":97},"2026-03-18","ACTUAL",{"date":99,"type":97},"2021-02-01",{"date":101,"type":85},"2027-01",{"name":5,"class":6},1]